TRIMETHOPRIM SULFAMETHOXAZOLE

Course overview

TRIMETHOPRIM/SULFAMETHOXAZOLE, ALSO KNOWN AS CO-TRIMOXAZOLE AND CAN BE ABBREVIATED IN THE FOLLOWING WAYS: SXT, TMP-SMX, TMP-SMZ, OR TMP-SULFA. IT IS AN ANTIMICROBIAL USED TO TREAT AND PREVENT MANY BACTERIAL INFECTIONS. THIS DRUG IS VERY COST AFFORDABLE AND USED FOR MANY TYPES OF ILLNESSES. THE FDA-APPROVED INDICATIONS INCLUDE ACUTE INFECTIVE EXACERBATION OF CHRONIC BRONCHITIS, OTITIS MEDIA IN PEDIATRICS ONLY, TRAVELERS DIARRHEA FOR TREATMENT AND PROPHYLAXIS, URINARY TRACT INFECTIONS, SHIGELLOSIS, PNEUMOCYSTIS JIROVECII, PNEUMONIA/PNEUMOCYSTIS CARINII PNEUMONIA (PJP/PCP), AND TOXOPLASMOSIS, BOTH AS PROPHYLAXIS AND TREATMENT. THERE ARE ALSO NON-FDA-APPROVED INDICATIONS. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, METHODS OF ADMINISTRATION, IMPORTANT ADVERSE EFFECTS, CONTRAINDICATIONS, TOXICITY, AND MONITORING, OF TMP-SMX, SO PROVIDERS CAN DIRECT PATIENT THERAPY WHERE NECESSARY FOR INFECTIONS AS PART OF THE INTERPROFESSIONAL TEAM.